References

Benign myalgic encephalomyelitis

10.1016/s0140-6736(57)90999-6 · 1957 · External reference

Infection elicited autoimmunity and Myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model

2018 · External reference

Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review

10.1136/bmjopen-2013-003973 · 2014 · External reference

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

10.1038/s41467-018-07598-9 · 2018 · External reference

Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols

2003 · External reference

Myalgic encephalomyelitis: international consensus criteria

10.1111/j.1365-2796.2011.02428.x · 2011 · External reference

Analysis of the Rituximab study and other immunological findings

2018 · External reference

B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with Rituximab maintenance treatment

10.1371/journal.pone.0129898 · 2015 · External reference

Myalgic encephaolomyelitis/chronic fatigue syndrome- evidence for an autoimmune disease

10.1016/j.autrev.2018.01.009 · 2018 · External reference

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

10.7326/0003-4819-121-12-199412150-00009 · 1994 · External reference

Benign myalgic encephalomyelitis

10.1016/s0140-6736(57)91024-3 · 1957 · External reference

Immunotherapy of fibromyalgia and chronic fatigue syndrome by a Staphylococcus toxoid vaccine

2009 · External reference

Stress-related exhaustion disorder--clinical manifestation of burnout? A review of assessment methods,sleep impairments, cognitive disturbances, and neuro-biological and physiologicalchanges in clinical burnout

10.1111/sjop.12251 · 2015 · External reference

Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist

10.1038/nature10753 · 2012 · External reference

Unresolved reference

2015 · External reference

A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

10.1186/s12881-016-0342-y · 2016 · External reference

Identifying symptom subgroups in patients with ME/CFS- relationships to functioning and quality of life

2017 · External reference

Antibodies to b adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome

10.1016/j.bbi.2015.09.013 · 2016 · External reference

Unresolved reference

2017 · External reference

Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care

10.1186/1741-7015-9-91 · 2011 · External reference

Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome

10.1186/s40168-017-0261-y · 2017 · External reference

The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE

10.1186/s12967-017-1263-z · 2017 · External reference

Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome

10.1371/journal.pone.0193672 · 2018 · External reference

Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration

10.1177/1756285616637046 · 2016 · External reference

Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome

2011 · External reference

Myalgic encephalomyelitis, chronic fatigue syndrome: an infectious disease

10.1016/j.mehy.2015.10.011 · 2015 · External reference

Possible biomarkers of chronic stress induced exhaustion - a longitudinal study

10.1371/journal.pone.0153924 · 2016 · External reference